Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Jul;70(7):4275–4282. doi: 10.1128/jvi.70.7.4275-4282.1996

Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.

R J Fingerote 1, M Abecassis 1, M J Phillips 1, Y S Rao 1, E H Cole 1, J Leibowitz 1, G A Levy 1
PMCID: PMC190359  PMID: 8676449

Abstract

Activation of the immune coagulation system has been implicated in the pathogenesis of liver injury following infection of inbred mice with murine hepatitis virus strain 3 (MHV-3). Following MHV-3 infection, macrophages isolated from MHV-3-susceptible and -semisusceptible inbred strains of mice express increased procoagulant activity (PCA), whereas macrophages from resistant strains express no increase in PCA over basal levels. The PCA induced by MHV-3 is a prothrombinase, encoded by the gene Fgl-2, which encodes a fibrinogen-like protein (musfiblp). In this study, MHV-3-resistant A/J mice treated with methylprednisolone prior to infection with MHV-3 developed elevated levels of alanine aminotransferase in serum and died within 10 days of infection, with histological findings of fulminant hepatitis. In vitro, macrophages isolated from A/J mice and pretreated with methylprednisolone produced a marked increase in functional PCA following infection with MHV-3. The PCA was shown to be a prothrombinase by its ability to cleave 125I-prothrombin. Northern blot analysis of RNA transcripts from these macrophages demonstrated increased transcription of the Fgl-2 gene relative to that in macrophages which had not been pretreated with methylprednisolone prior to MHV-3 infection. Methylprednisolone pretreatment of MHV-3-infected macrophages stabilized the Fgl-2 mRNA. Thus, loss of resistance to MHV-3 secondary to methylprednisolone therapy is associated with increased transcription and stability of Fgl-2 mRNA resulting in expression of the Fgl-2 gene product, musfiblp. These results provide further insight into mechanisms of PCA regulation in response to MHV-3 infection in inbred strains of mice.

Full Text

The Full Text of this article is available as a PDF (709.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abecassis M., Falk J. A., Makowka L., Dindzans V. J., Falk R. E., Levy G. A. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest. 1987 Sep;80(3):881–889. doi: 10.1172/JCI113147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buschman E., Skamene E. Genetic resistance to coronavirus infection. A review. Adv Exp Med Biol. 1995;380:1–11. doi: 10.1007/978-1-4615-1899-0_1. [DOI] [PubMed] [Google Scholar]
  3. Chung S., Gorczynski R., Cruz B., Fingerote R., Skamene E., Perlman S., Leibowitz J., Fung L., Flowers M., Levy G. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo. Immunology. 1994 Nov;83(3):353–361. [PMC free article] [PubMed] [Google Scholar]
  4. Datta D. V., Isselbacher K. J. Effects of corticosteroids on mouse hepatitis virus infection. Gut. 1969 Jul;10(7):522–529. doi: 10.1136/gut.10.7.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daynes R. A., Araneo B. A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol. 1989 Dec;19(12):2319–2325. doi: 10.1002/eji.1830191221. [DOI] [PubMed] [Google Scholar]
  6. Dindzans V. J., MacPhee P. J., Fung L. S., Leibowitz J. L., Levy G. A. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo. J Immunol. 1985 Dec;135(6):4189–4197. [PubMed] [Google Scholar]
  7. Dindzans V. J., Skamene E., Levy G. A. Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genes. J Immunol. 1986 Oct 1;137(7):2355–2360. [PubMed] [Google Scholar]
  8. Evans R., Kamdar S. J. Stability of RNA isolated from macrophages depends on the removal of an RNA-degrading activity early in the extraction procedure. Biotechniques. 1990 Apr;8(4):357–360. [PubMed] [Google Scholar]
  9. Fung L. S., Neil G., Leibowitz J., Cole E. H., Chung S., Crow A., Levy G. A. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J Biol Chem. 1991 Jan 25;266(3):1789–1795. [PubMed] [Google Scholar]
  10. GALLILY R., WARWICK A., BANG F. B. EFFECT OF CORTISONE OF GENETIC RESISTANCE TO MOUSE HEPATITIS VIRUS IN VIVO AND IN VITRO. Proc Natl Acad Sci U S A. 1964 Jun;51:1158–1164. doi: 10.1073/pnas.51.6.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gonzalo J. A., González-García A., Martínez C., Kroemer G. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J Exp Med. 1993 May 1;177(5):1239–1246. doi: 10.1084/jem.177.5.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HENRY R. J., CHIAMORI N., GOLUB O. J., BERKMAN S. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol. 1960 Oct;34:381–398. doi: 10.1093/ajcp/34.4_ts.381. [DOI] [PubMed] [Google Scholar]
  13. Hirano N., Fujiwara K., Hino S., Matumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch. 1974;44(3):298–302. doi: 10.1007/BF01240618. [DOI] [PubMed] [Google Scholar]
  14. Jackson R. J. Cytoplasmic regulation of mRNA function: the importance of the 3' untranslated region. Cell. 1993 Jul 16;74(1):9–14. doi: 10.1016/0092-8674(93)90290-7. [DOI] [PubMed] [Google Scholar]
  15. Koyama T., Hall L. R., Haser W. G., Tonegawa S., Saito H. Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. Proc Natl Acad Sci U S A. 1987 Mar;84(6):1609–1613. doi: 10.1073/pnas.84.6.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Langley P. G., Forbes A., Hughes R. D., Williams R. Thrombin-antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome. Eur J Clin Invest. 1990 Dec;20(6):627–631. doi: 10.1111/j.1365-2362.1990.tb01911.x. [DOI] [PubMed] [Google Scholar]
  17. Le Prevost C., Levy-Leblond E., Virelizier J. L., Dupuy J. M. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms. J Immunol. 1975 Jan;114(1 Pt 1):221–225. [PubMed] [Google Scholar]
  18. Lee W. M. Acute liver failure. N Engl J Med. 1993 Dec 16;329(25):1862–1872. doi: 10.1056/NEJM199312163292508. [DOI] [PubMed] [Google Scholar]
  19. Levy G. A., Leibowitz J. L., Edgington T. S. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med. 1981 Oct 1;154(4):1150–1163. doi: 10.1084/jem.154.4.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levy G. A., Leibowitz J. L., Edgington T. S. Lymphocyte-instructed monocyte induction of the coagulation pathways parallels the induction of hepatitis by the murine hepatitis virus. Prog Liver Dis. 1982;7:393–409. [PubMed] [Google Scholar]
  21. Li C., Fung L. S., Chung S., Crow A., Myers-Mason N., Phillips M. J., Leibowitz J. L., Cole E., Ottaway C. A., Levy G. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med. 1992 Sep 1;176(3):689–697. doi: 10.1084/jem.176.3.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lucas A., Flintoff W., Anderson R., Percy D., Coulter M., Dales S. In vivo and in vitro models of demyelinating diseases: tropism of the JHM strain of murine hepatitis virus for cells of glial origin. Cell. 1977 Oct;12(2):553–560. doi: 10.1016/0092-8674(77)90131-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MacPhee P. J., Dindzans V. J., Fung L. S., Levy G. A. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3. Hepatology. 1985 Jul-Aug;5(4):649–660. doi: 10.1002/hep.1840050422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Macnaughton M. R., Patterson S. Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages. Brief report. Arch Virol. 1980;66(1):71–75. doi: 10.1007/BF01315046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mori W., Aoki N., Shiga J. Acute hepatic cell necrosis experimentally produced by viral agents in rabbits. Am J Pathol. 1981 Apr;103(1):31–38. [PMC free article] [PubMed] [Google Scholar]
  26. Mori W., Machinami R., Shiga J., Taguchi T., Tanaka K., Fukusato T., Hasegawa A., Aoki N., Narita T., Kikuchi F. A pathological study of fulminant hepatic disease. Acta Pathol Jpn. 1984 Jul;34(4):727–742. doi: 10.1111/j.1440-1827.1984.tb07601.x. [DOI] [PubMed] [Google Scholar]
  27. Mori W., Shiga J., Irie H. Shwartzman reaction as a pathogenetic mechanism in fulminant hepatitis. Semin Liver Dis. 1986 Aug;6(3):267–276. doi: 10.1055/s-2008-1040609. [DOI] [PubMed] [Google Scholar]
  28. Parr R. L., Fung L., Reneker J., Myers-Mason N., Leibowitz J. L., Levy G. Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J Virol. 1995 Aug;69(8):5033–5038. doi: 10.1128/jvi.69.8.5033-5038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Qureshi S. T., Clermont S., Leibowitz J., Fung L. S., Levy G., Malo D. Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5. Genomics. 1995 Sep 1;29(1):307–309. doi: 10.1006/geno.1995.1256. [DOI] [PubMed] [Google Scholar]
  30. Rake M. O., Flute P. T., Shilkin K. B., Lewis M. L., Winch J., Williams R. Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet. 1971 Dec 4;2(7736):1215–1218. doi: 10.1016/s0140-6736(71)90540-x. [DOI] [PubMed] [Google Scholar]
  31. Sachs A. B. Messenger RNA degradation in eukaryotes. Cell. 1993 Aug 13;74(3):413–421. doi: 10.1016/0092-8674(93)80043-e. [DOI] [PubMed] [Google Scholar]
  32. Schwartz B. S., Levy G. A., Fair D. S., Edgington T. S. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med. 1982 May 1;155(5):1464–1479. doi: 10.1084/jem.155.5.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986 Aug 29;46(5):659–667. doi: 10.1016/0092-8674(86)90341-7. [DOI] [PubMed] [Google Scholar]
  34. Sinclair S. B., Greig P. D., Blendis L. M., Abecassis M., Roberts E. A., Phillips M. J., Cameron R., Levy G. A. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest. 1989 Oct;84(4):1063–1069. doi: 10.1172/JCI114268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sinclair S. B., Rotstein O. D., Levy G. A. Disparate mechanisms of induction of procoagulant activity by live and inactivated bacteria and viruses. Infect Immun. 1990 Jun;58(6):1821–1827. doi: 10.1128/iai.58.6.1821-1827.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sturman L. S., Takemoto K. K. Enhanced growth of a murine coronavirus in transformed mouse cells. Infect Immun. 1972 Oct;6(4):501–507. doi: 10.1128/iai.6.4.501-507.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. The T. H., Feltkamp T. E. Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation. Immunology. 1970 Jun;18(6):865–873. [PMC free article] [PubMed] [Google Scholar]
  38. Tokunaga K., Nakamura Y., Sakata K., Fujimori K., Ohkubo M., Sawada K., Sakiyama S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 1987 Nov 1;47(21):5616–5619. [PubMed] [Google Scholar]
  39. Vacca A., Felli M. P., Farina A. R., Martinotti S., Maroder M., Screpanti I., Meco D., Petrangeli E., Frati L., Gulino A. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med. 1992 Mar 1;175(3):637–646. doi: 10.1084/jem.175.3.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Virelizier J. L., Allison A. C. Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures. Arch Virol. 1976;50(4):279–285. doi: 10.1007/BF01317953. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES